back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-06-14 12:58 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+400,000 vol |
400,000 | |
| Filed 2022-06-14 12:58 Tx date 2019-10-01 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-14 12:58 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$60,000
+400,000 vol $0.15 each |
400,000 | |
| Filed 2022-06-14 12:57 Tx date 2019-10-01 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-03 17:10 Tx date 2021-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+1,400,000 vol |
2,200,000 | |
| Filed 2021-06-03 17:06 Tx date 2021-05-31 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+600,000 vol |
1,400,000 | |
| Filed 2019-11-29 14:49 Tx date 2019-11-27 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+800,000 vol |
800,000 | |
| Filed 2019-11-29 14:47 Tx date 2019-10-01 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-29 14:47 Tx date 2019-11-25 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+800,000 vol |
800,000 | |
| Filed 2019-11-29 14:46 Tx date 2019-10-01 |
$KHRN
Khiron Life Sciences Corp. |
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|